Inactive Instrument
ENTST BIO Share Price Other OTC
Stocks
Investment Holding Companies
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 21/01/20 | Entest Group, Inc. Reports Earnings Results for the First Quarter Ended November 30, 2019 | CI |
| 20/12/19 | Entest Group, Inc. Reports Earnings Results for the Full Year Ended August 31, 2019 | CI |
| Market Cap | 541K 468K 436K 401K 758K 51.59M 768K 5.14M 2.02M 25.68M 2.03M 1.99M 85.1M | P/E 2018 |
-0.92x | P/E 2019 | 12.6x |
|---|---|---|---|---|---|
| Enterprise Value | 562K 487K 453K 416K 788K 53.62M 798K 5.34M 2.09M 26.69M 2.11M 2.06M 88.44M | EV / Sales 2018 |
-
| EV / Sales 2019 | - |
| Free-Float |
98.54% | Yield 2018 * |
-
| Yield 2019 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.93% | -6.72% | -53.83% | - | 13.74B | |
| +11.61% | -0.80% | +5.49% | - | 1.26B | |
| -1.00% | +1.32% | - | - | 772M | |
| -0.10% | +0.10% | - | - | 644M | |
| -.--% | -6.95% | +268.42% | -68.57% | 621M | |
| +0.24% | -2.30% | - | - | 607M | |
| -.--% | -0.05% | - | - | 597M | |
| -.--% | -0.86% | - | - | 595M | |
| Average | +1.10% | +0.68% | +73.36% | -68.57% | 2.35B | |
| Weighted average by Cap. | -0.67% | +11.44% | -36.23% | -68.57% |
| 2018 | 2019 | |
|---|---|---|
| Net sales | - | - |
| Net income | -1.48M -1.28M -1.19M -1.09M -2.07M -141M -2.1M -14.05M -5.5M -70.15M -5.55M -5.43M -232M | 192K 166K 155K 142K 268K 18.28M 272K 1.82M 714K 9.1M 720K 704K 30.15M |
| Net Debt | 19.4K 16.8K 15.65K 14.37K 27.18K 1.85M 27.54K 184K 72.28K 921K 72.85K 71.25K 3.05M | 21.2K 18.35K 17.1K 15.7K 29.7K 2.02M 30.09K 202K 78.97K 1.01M 79.6K 77.85K 3.34M |
Employees
-
Sector
Investment Holding Companies
Select your edition
All financial news and data tailored to specific country editions
